Findings in Journal of the National Cancer Institute shows patients don’t have enough opportunities for participation
Summaries of recent Fred Hutch research.
Summaries of recent Fred Hutch research, with links for additional background and media contacts.
Summaries of this year’s notable advances at Fred Hutchinson Cancer Research Center and beyond.
Summaries of recent Fred Hutch research with links for additional background and media contacts.
Large-scale genomic study discovers 40 new genetic variants associated with colorectal cancer risk
Fred Hutchinson Cancer Research Center’s latest findings on cancer immunotherapies, CRISPR for blood disorders, stem cell transplantation and insights on the immune system and cancer will be featured at the 60th annual meeting of the American Society of Hematology, which will be held Dec. 1–4 in San Diego.
Study confirms biological mechanism responsible for latent HIV reservoirs; suggests strategies for a functional HIV cure
This month's Fred Hutch tip sheet includes story ideas about understanding how skin stops tumor growth, advances in studying Kasposi sarcoma, and forecasting the flu. To pursue any of these stories ideas, contact the person listed.
Fred Hutch is committed to better understanding prostate cancer, creating new treatment therapies and technologies and ultimately, finding a cure. This tip sheet includes brief summaries of the work our researchers are doing around prostate cancer and some high-level points to be aware of.
This month's tip sheet from Fred Hutch highlights research related to cancer-causing bacteria, a cancer 'escape hatch,' how sex cells sort chromosomes, cord blood's role in leukemia treatment and more.
Fred Hutchinson Cancer Research Center is committed to reducing breast cancer incidence and death by identifying risk factors for the disease, developing new methods of detecting it and helping to predict health outcomes based on a woman’s genetics and other factors. This tip sheet includes brief summaries of the work our researchers are doing around breast cancer and some high-level points to be aware of in anticipation of Breast Cancer Awareness Month in October.
Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term. In an effort to find out why, Fred Hutchinson Cancer Research Center scientists are using a new technology to look at how cancer cells change under the pressure of immunotherapy treatments.
The August tip sheet from Fred Hutch includes story ideas about next-gen CAR T-cell immunotherapies, cancer care disparities in rural and urban settings, organizing chromosomes in egg and sperm cells, decoding our immune system's memories and more.
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded to other treatments. But until now, the underlying biological pathways enabling anti-cancer responses have not been thoroughly examined.
When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show.
Fred Hutchinson Cancer Research Center announced it received a five year Science Education Partnership Award (SEPA) from The National Institute of General Medical Sciences (NIGMS), worth $1.26 million.
This month's medical tip sheet from Fred Hutchinson Cancer Research Center includes stories about acupuncture for breast cancer patients, nanoparticles that pave the way for CAR T-cell immunotherapy in solid tumors and the link between childhood abuse and endometriosis later on in life. Also included is information on several awards and recognitions.
A study of more than 60,000 women has found that sexual and physical abuse in childhood and adolescence is associated with a greater risk of laparoscopically-confirmed endometriosis diagnosed during adulthood. The study – the largest of its kind – found that women reporting severe-chronic abuse of multiple types had a 79 percent higher risk of laparoscopically-confirmed endometriosis.
This month's tip sheet from Fred Hutch includes story ideas about immunotherapy for a deadly type of skin cancer, cancer care that costs twice as much but yields no better outcome, yoga and music therapies for breast cancer and more. To pursue any of these story ideas, please contact the individual listed for each.
A breast cancer patient dealing with anxiety, depression or mood swings could soon be encouraged by her oncologist to learn meditation techniques, join a yoga class or put music to therapeutic use. Today, the American Society of Clinical Oncology (ASCO), published its endorsement of integrative therapy guidelines recently established by the Society for Integrative Oncology (SIO).
Fred Hutchinson Cancer Research Center announced the election of a new board of trustees chair, a new vice chair and two new members. Each brings additional expertise in finance, technology, bioscience and data science as the Hutch accelerates efforts to develop cures for cancer and other diseases.
This month's tip sheet from Fred Hutch includes information about cancer care delivery and costs, partnering with Microsoft, understanding/changing cancer's genetics and a Mt. Everest climb for cancer research fundraising. To pursue any of these story ideas, please contact the individual listed for each.
Fred Hutchinson Cancer Research Center’s latest findings will be featured at the annual meeting of the American Society of Clinical Oncology, “Delivering Discoveries: Expanding the Reach of Precision Medicine,” to be held June 1–5 in Chicago. Here are several highlights:
This month's tip sheet from Fred Hutchinson Cancer Research Center includes story ideas about moving toward a vaccine for Epstein-Barr virus, tissue samples from 1989 that have led to CMV breakthroughs today, immunotherapy advances and research related to brain cancer and head and neck tumors.
Fred Hutchinson Cancer Research Center’s latest findings will be featured in about 50 presentations at the annual meeting of the American Association for Cancer Research, “Driving Innovative Cancer Science to Patient Care,” to be held April 14-18 in Chicago. Here are several highlights:
The Fred Hutch Tip Sheet includes story ideas about: New paths to malaria prevention; proteins involved in muscular dystrophy; pathogen-associated cancers; lung cancer in women who never smoked; financial impact of cancer care; more
It’s the second-most common cancer killer in the U.S., but misconceptions about colorectal cancer can keep people from accessing the preventive care and treatment they might need. Fred Hutchinson Cancer Research Center experts address some of the most misunderstood aspects of this disease.
Fred Hutchinson Cancer Research Center has announced the 2018 recipients of the annual Harold M. Weintraub Graduate Student Award, which recognizes outstanding achievement in graduate studies in the biological sciences. Nominations for this prestigious award are solicited internationally. This year’s 13 awardees come from the University of Vienna and across the United States.
The February Fred Hutch tip sheet includes story ideas ranging from cancer immunotherapy to cloud computing, flu prevention for cancer patients, cystine-dense peptides found in many deadly venoms, gene therapies, serendipitous findings and more.
Collaboration aims to accelerate next generation treatments in cancer, gastrointestinal diseases, and neurological disorders
Below is the December tip sheet from Fred Hutchinson Cancer Research Center. Story ideas include new research on leukemia therapies, racial disparities in end-of-life care, an experimental drug for pancreatic cancer and more.
The October tip sheet from Fred Hutchinson Cancer Research Center includes story ideas about a new take on prostate cancer screening; fruit fly obesity; nanoparticles for gene therapy; TCRs for relapsing leukemia and more. Each tip links to more detailed information and includes contact information for arranging interviews.
Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse. The findings provide the basis for launching a first-in-human clinical trial of this new immunotherapy, which relies on engineered T-cell receptors, or TCRs.
Two new papers from researchers at Fred Hutchinson Cancer Research Center provide the most comprehensive data yet reported on side effects of the emerging cancer immunotherapy strategy known as CAR T-cell therapy.
A new biomedical tool using nanoparticles that deliver transient gene changes to targeted cells could make therapies for a variety of diseases — including cancer, diabetes and HIV — faster and cheaper to develop, and more customizable.
The August tip sheet from Fred Hutch includes stories on breast cancer, skin cells as a cancer repair mechanism, an HIV prevention study, air pollution risk and more -- Here are quick summaries for journalists that offer sources and story ideas from Fred Hutch.
Fred Hutchinson Cancer Research Center is launching a new integrated research center to prevent and find cures for cancers caused by infectious agents. It will be led by Dr. Denise Galloway, a Fred Hutch microbiologist whose research paved the way for the HPV vaccine, which prevents cervical, throat and other cancers.
Quick summaries for journalists that offer sources and story ideas from Fred Hutch. Each links to more detailed information and includes contact information for arranging interviews. Topics include Glioblastoma, tumor microenvironment and more.
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric antigen receptor (CAR) T-cell immunotherapy. The researchers also found that measuring genetic traces of cancer cells taken from bone marrow biopsies might be a better indicator of prognosis than the standard lymph node scan.
Fred Hutchinson Cancer Research Center’s board of trustees yesterday elected three new members, adding expertise in information technology, media and global health as it works to accelerate efforts to develop cures for cancer and other diseases.
Dr. Amanda Paulovich of Fred Hutch will lead a multi-institution effort to develop a biological test to predict which treatments will work for patients with ovarian cancer. Photos, video available: http://www.fredhutch.org/en/news/media-relations/bios-photos/paulovich-amanda/photos-graphics-video.html
A Fred Hutchinson Cancer Research Center study, led by epidemiologist Dr. Parveen Bhatti, found that night shift work is associated with reduced ability to repair DNA lesions. Over time, DNA damage that is not repaired will cause mutations that can lead to cancer.
Among long-term colorectal cancer survivors, use of nonsteroidal anti-inflammatory drugs, or NSAIDs, is associated with about a 25 percent reduction in all-cause mortality, according to new research from Fred Hutchinson Cancer Research Center.
For an investment of $125 for each year of life gained since the 1950s, the National Cancer Institute-funded SWOG clinical trials program has added 3.34 million years of life for cancer patients in the United States because of successful therapies that were proved through its trials.That is the conclusion of an analysis, led by a faculty member at Fred Hutchinson Cancer Research Center, of outcomes data from 193 randomized Phase III clinical trials tested by SWOG.
The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects. The findings will be presented by Dr. Seth Pollack, a physician-scientist at Fred Hutchinson Cancer Research Center, June 5 in a poster at the American Society of Clinical Oncology annual meeting in Chicago.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right